Chemoprevention of hepatocellular carcinoma in aflatoxin endemic areas.

Hepatocellular carcinoma is one of the most common cancers worldwide. Infection with hepatitis B virus and exposure to aflatoxins in the diet act synergistically to amplify risk. From a public health perspective, hepatitis virus vaccination programs and efforts to both reduce aflatoxin exposures and to attenuate the toxicological consequences of unavoidable exposures should have major impacts on the global incidence of this disease. Experimentally, aflatoxin-induced hepatocarcinogenesis can be inhibited by over a score of different chemopreventive agents with multiple mechanisms of action. One agent, oltipraz, is a potent inducer of phase 2 enzymes involved in the detoxication of carcinogens including aflatoxin. A second agent, chlorophyllin, impedes the bioavailability of carcinogens by forming molecular complexes and enhances their elimination in the fecal stream. This review highlights the findings of recent randomized clinical trials with oltipraz and chlorophyllin conducted in individuals exposed to dietary aflatoxins and at high risk for development of liver cancer. Both chemopreventive agents modulated levels of aflatoxin biomarkers in the study participants in manners consonant with protection. Although pharmacological approaches establish proof of principle and help identify key molecular targets for interventions, food-based approaches that also use these molecular targets may be the most practical for widespread application in high-risk populations.
AuthorsThomas W Kensler, Patricia A Egner, Jin-Bing Wang, Yuan-Rong Zhu, Bao-Chu Zhang, Pei-Xin Lu, Jian-Guo Chen, Geng-Sun Qian, Shuang-Yuan Kuang, Peta E Jackson, Stephen J Gange, Lisa P Jacobson, Alvaro Muñoz, John D Groopman
JournalGastroenterology (Gastroenterology) Vol. 127 Issue 5 Suppl 1 Pg. S310-8 (Nov 2004) ISSN: 0016-5085 [Print] United States
PMID15508099 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S., Review)
Chemical References
  • Aflatoxins
  • Anticarcinogenic Agents
  • Antimutagenic Agents
  • Aflatoxins (adverse effects)
  • Anticarcinogenic Agents (therapeutic use)
  • Antimutagenic Agents (therapeutic use)
  • Carcinoma, Hepatocellular (etiology, prevention & control)
  • Chemoprevention
  • Diet
  • Food Contamination
  • Humans
  • Liver Neoplasms (etiology, prevention & control)
  • Randomized Controlled Trials as Topic
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: